We have access to a diverse range of well-characterised paediatric clinical cohorts across the full range of childhood conditions.
For rare diseases, we work in clinical networks across the region and can arrange opportunities for children from other Trusts to participate to help ensure recruitment.
With these clinical cohorts, we can support a range of study types including pharmacokinetic and safety studies, efficacy studies, diagnostics and devices.
As a combined secondary, tertiary, and quaternary centre, we have large volumes of patients across common conditions of childhood and services managing rarer conditions and orphan diseases. We also have extensive community and mental health services, providing access to children and young people managed outside the hospital setting.
We have extensive experience and expertise in study feasibility assessments, offering an accurate estimation of the size and suitability of potential study cohorts enabling precise and optimal costing of studies.
Our internationally renowned Children and Young Persons Advisory Group (YPAG) provides an unparalleled service for sponsors in providing feedback on the acceptability of specific procedures and protocols. In addition, the YPAG is proficient in working with sponsors internationally in the co-design of study protocols and protocol simulations.